位置:首页 > 蛋白库 > SSH3_HUMAN
SSH3_HUMAN
ID   SSH3_HUMAN              Reviewed;         659 AA.
AC   Q8TE77; Q6PK42; Q76I75; Q8N9L8; Q8WYL0; Q9NV45; Q9NWZ7;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   22-NOV-2005, sequence version 2.
DT   03-AUG-2022, entry version 166.
DE   RecName: Full=Protein phosphatase Slingshot homolog 3;
DE            EC=3.1.3.16;
DE            EC=3.1.3.48;
DE   AltName: Full=SSH-like protein 3;
DE            Short=SSH-3L;
DE            Short=hSSH-3L;
GN   Name=SSH3; Synonyms=SSH3L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=11832213; DOI=10.1016/s0092-8674(01)00638-9;
RA   Niwa R., Nagata-Ohashi K., Takeichi M., Mizuno K., Uemura T.;
RT   "Control of actin reorganization by Slingshot, a family of phosphatases
RT   that dephosphorylate ADF/cofilin.";
RL   Cell 108:233-246(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=14531860; DOI=10.1046/j.1365-2443.2003.00678.x;
RA   Ohta Y., Kousaka K., Nagata-Ohashi K., Ohashi K., Muramoto A., Shima Y.,
RA   Niwa R., Uemura T., Mizuno K.;
RT   "Differential activities, subcellular distribution and tissue expression
RT   patterns of three members of Slingshot family phosphatases that
RT   dephosphorylate cofilin.";
RL   Genes Cells 8:811-824(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3; 4 AND 5).
RC   TISSUE=Cerebellum, and Ovarian carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85 AND SER-87, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9 AND SER-37, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9; SER-37 AND SER-87, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Protein phosphatase which may play a role in the regulation
CC       of actin filament dynamics. Can dephosphorylate and activate the actin
CC       binding/depolymerizing factor cofilin, which subsequently binds to
CC       actin filaments and stimulates their disassembly (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:83421; EC=3.1.3.16;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:61977; EC=3.1.3.16;
CC   -!- SUBUNIT: Does not bind to, or colocalize with, filamentous actin.
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8TE77; O43639: NCK2; NbExp=3; IntAct=EBI-8743776, EBI-713635;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Nucleus
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=L;
CC         IsoId=Q8TE77-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TE77-2; Sequence=VSP_016335, VSP_016336;
CC       Name=3;
CC         IsoId=Q8TE77-3; Sequence=VSP_016331, VSP_016332;
CC       Name=4;
CC         IsoId=Q8TE77-4; Sequence=VSP_016333;
CC       Name=5;
CC         IsoId=Q8TE77-5; Sequence=VSP_016330, VSP_016334, VSP_016335,
CC                                  VSP_016336;
CC   -!- MISCELLANEOUS: Tyrosine phosphatase activity has not been demonstrated
CC       for this protein to date.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB072360; BAB84119.3; -; mRNA.
DR   EMBL; AB099291; BAC97814.1; -; mRNA.
DR   EMBL; AK000522; BAA91228.1; -; mRNA.
DR   EMBL; AK001790; BAA91913.1; -; mRNA.
DR   EMBL; AK074432; BAB85080.1; -; mRNA.
DR   EMBL; AK094226; BAC04314.1; -; mRNA.
DR   EMBL; BC007709; AAH07709.1; -; mRNA.
DR   CCDS; CCDS8157.1; -. [Q8TE77-1]
DR   RefSeq; NP_060327.3; NM_017857.3. [Q8TE77-1]
DR   AlphaFoldDB; Q8TE77; -.
DR   SMR; Q8TE77; -.
DR   BioGRID; 120299; 55.
DR   IntAct; Q8TE77; 26.
DR   MINT; Q8TE77; -.
DR   STRING; 9606.ENSP00000312081; -.
DR   DEPOD; SSH3; -.
DR   GlyGen; Q8TE77; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8TE77; -.
DR   PhosphoSitePlus; Q8TE77; -.
DR   BioMuta; SSH3; -.
DR   DMDM; 82582268; -.
DR   CPTAC; CPTAC-591; -.
DR   CPTAC; CPTAC-592; -.
DR   EPD; Q8TE77; -.
DR   jPOST; Q8TE77; -.
DR   MassIVE; Q8TE77; -.
DR   MaxQB; Q8TE77; -.
DR   PaxDb; Q8TE77; -.
DR   PeptideAtlas; Q8TE77; -.
DR   PRIDE; Q8TE77; -.
DR   ProteomicsDB; 74414; -. [Q8TE77-1]
DR   ProteomicsDB; 74415; -. [Q8TE77-2]
DR   ProteomicsDB; 74416; -. [Q8TE77-3]
DR   ProteomicsDB; 74417; -. [Q8TE77-4]
DR   ProteomicsDB; 74418; -. [Q8TE77-5]
DR   Antibodypedia; 16449; 233 antibodies from 32 providers.
DR   DNASU; 54961; -.
DR   Ensembl; ENST00000308127.9; ENSP00000312081.4; ENSG00000172830.13. [Q8TE77-1]
DR   Ensembl; ENST00000376757.9; ENSP00000365948.6; ENSG00000172830.13. [Q8TE77-3]
DR   Ensembl; ENST00000532881.5; ENSP00000431788.2; ENSG00000172830.13. [Q8TE77-2]
DR   GeneID; 54961; -.
DR   KEGG; hsa:54961; -.
DR   MANE-Select; ENST00000308127.9; ENSP00000312081.4; NM_017857.4; NP_060327.3.
DR   UCSC; uc001okj.4; human. [Q8TE77-1]
DR   CTD; 54961; -.
DR   DisGeNET; 54961; -.
DR   GeneCards; SSH3; -.
DR   HGNC; HGNC:30581; SSH3.
DR   HPA; ENSG00000172830; Low tissue specificity.
DR   MIM; 606780; gene.
DR   neXtProt; NX_Q8TE77; -.
DR   OpenTargets; ENSG00000172830; -.
DR   PharmGKB; PA134929326; -.
DR   VEuPathDB; HostDB:ENSG00000172830; -.
DR   eggNOG; KOG1716; Eukaryota.
DR   GeneTree; ENSGT00940000160322; -.
DR   HOGENOM; CLU_006650_3_1_1; -.
DR   InParanoid; Q8TE77; -.
DR   OMA; QSHIWEQ; -.
DR   PhylomeDB; Q8TE77; -.
DR   TreeFam; TF319444; -.
DR   PathwayCommons; Q8TE77; -.
DR   SignaLink; Q8TE77; -.
DR   SIGNOR; Q8TE77; -.
DR   BioGRID-ORCS; 54961; 12 hits in 1078 CRISPR screens.
DR   ChiTaRS; SSH3; human.
DR   GeneWiki; SSH3; -.
DR   GenomeRNAi; 54961; -.
DR   Pharos; Q8TE77; Tbio.
DR   PRO; PR:Q8TE77; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q8TE77; protein.
DR   Bgee; ENSG00000172830; Expressed in lower esophagus mucosa and 179 other tissues.
DR   ExpressionAtlas; Q8TE77; baseline and differential.
DR   Genevisible; Q8TE77; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003779; F:actin binding; IBA:GO_Central.
DR   GO; GO:0017018; F:myosin phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IBA:GO_Central.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0030837; P:negative regulation of actin filament polymerization; IBA:GO_Central.
DR   GO; GO:0006470; P:protein dephosphorylation; IEA:InterPro.
DR   CDD; cd11652; SSH-N; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR014876; DEK_C.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR043587; Phosphatase_SSH-like.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR043588; SSH-N.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   PANTHER; PTHR45864; PTHR45864; 1.
DR   Pfam; PF08766; DEK_C; 1.
DR   Pfam; PF00782; DSPc; 1.
DR   SMART; SM00195; DSPc; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS51998; DEK_C; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cytoplasm; Cytoskeleton; Hydrolase;
KW   Nucleus; Phosphoprotein; Protein phosphatase; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K330"
FT   CHAIN           2..659
FT                   /note="Protein phosphatase Slingshot homolog 3"
FT                   /id="PRO_0000094845"
FT   DOMAIN          269..324
FT                   /note="DEK-C"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01342"
FT   DOMAIN          328..469
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          46..96
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          482..534
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          547..603
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          617..638
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        60..78
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        491..505
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        509..530
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        547..563
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        617..635
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        413
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K330"
FT   MOD_RES         9
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         85
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17525332"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17525332,
FT                   ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         1..330
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_016330"
FT   VAR_SEQ         1..146
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_016331"
FT   VAR_SEQ         147..154
FT                   /note="LGVDFPDS -> MAFPLSPA (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_016332"
FT   VAR_SEQ         283..547
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_016333"
FT   VAR_SEQ         331..360
FT                   /note="RIFPHLYLGSEWNAANLEELQRNRVTHILN -> MEGTMMMQQRPVLSQQHP
FT                   SFILNSSPAHSP (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_016334"
FT   VAR_SEQ         470..471
FT                   /note="SR -> RT (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11832213,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_016335"
FT   VAR_SEQ         472..659
FT                   /note="Missing (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11832213,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_016336"
FT   VARIANT         239
FT                   /note="E -> V (in dbSNP:rs7114712)"
FT                   /id="VAR_057132"
FT   VARIANT         600
FT                   /note="R -> H (in dbSNP:rs1573536)"
FT                   /id="VAR_057133"
FT   CONFLICT        58
FT                   /note="A -> V (in Ref. 1 and 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        509
FT                   /note="E -> G (in Ref. 3; BAC04314)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        641
FT                   /note="F -> S (in Ref. 3; BAB85080)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   659 AA;  72996 MW;  0D96F86EAFE81D3B CRC64;
     MALVTVSRSP PGSGASTPVG PWDQAVQRRS RLQRRQSFAV LRGAVLGLQD GGDNDDAAEA
     SSEPTEKAPS EEELHGDQTD FGQGSQSPQK QEEQRQHLHL MVQLLRPQDD IRLAAQLEAP
     RPPRLRYLLV VSTREGEGLS QDETVLLGVD FPDSSSPSCT LGLVLPLWSD TQVYLDGDGG
     FSVTSGGQSR IFKPISIQTM WATLQVLHQA CEAALGSGLV PGGSALTWAS HYQERLNSEQ
     SCLNEWTAMA DLESLRPPSA EPGGSSEQEQ MEQAIRAELW KVLDVSDLES VTSKEIRQAL
     ELRLGLPLQQ YRDFIDNQML LLVAQRDRAS RIFPHLYLGS EWNAANLEEL QRNRVTHILN
     MAREIDNFYP ERFTYHNVRL WDEESAQLLP HWKETHRFIE AARAQGTHVL VHCKMGVSRS
     AATVLAYAMK QYECSLEQAL RHVQELRPIA RPNPGFLRQL QIYQGILTAS RQSHVWEQKV
     GGVSPEEHPA PEVSTPFPPL PPEPEGGGEE KVVGMEESQA APKEEPGPRP RINLRGVMRS
     ISLLEPSLEL ESTSETSDMP EVFSSHESSH EEPLQPFPQL ARTKGGQQVD RGPQPALKSR
     QSVVTLQGSA VVANRTQAFQ EQEQGQGQGQ GEPCISSTPR FRKVVRQASV HDSGEEGEA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024